Birnam Oak Advisors, LP / VRNA
Birnam Oak Advisors, LP’s Verona Pharma PLC Position
Does Birnam Oak Advisors, LP own Verona Pharma PLC (VRNA)? Not currently — the last reported position was 277.6K shares worth $30M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$30M
Q3 2025
Shares
277.6K
% of Portfolio
+6.80%
Quarters Held
1
position exited
Position History VRNA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2025 | 277.6K | $30M | +6.80% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birnam Oak Advisors, LP’s full portfolio or all institutional holders of VRNA.